Displaying 1-3 of 3 results
XIX International AIDS Conference. Interview with Gregg Alton from the Gilead Sciences, Inc. a pharmaceutical company working with health care services, policy makers, etc. to develop effective treatment, treatment as prevention and promoting access to care.
XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.
XIX International AIDS Conference. Interview with the Immunologist Michael Elliot from University of Rochester on the CNIHR program which involves scientist not previously engaged in the HIV research field to develop new thinking withing the field.